Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways
- PMID: 20954819
- DOI: 10.1089/thy.2010.0123
Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways
Abstract
Background: Both expression of the thyrotropin receptor (TSHR) and the production of hyaluronan (HA) by orbital fibroblasts (OF) have been proposed to be implicated in the pathogenesis of Graves' ophthalmopathy (GO). HA is synthesized by three types of HA synthase. We hypothesized that TSHR activation by recombinant human TSH (rhTSH) and TSHR-stimulating Graves' disease immunoglobulins (GD-IgGs) via induced cyclic adenosine monophosphate (cAMP) signaling increases HA synthesis in differentiated OF from GO patients.
Methods: Cultured human OF, obtained during decompression surgery from 17 patients with severe GO, were stimulated in vitro to differentiate into adipocytes. Differentiation was evaluated by phase-contrast microscopy. The differentiated OF were stimulated by rhTSH or by TSHR-stimulating GD-IgG. We measured cAMP using a biochemical assay, HA synthase mRNA expression by quantitative polymerase chain reaction, and HA in the supernatant by enzyme-linked immunosorbent assay.
Results: All differentiated OF cultures expressed higher levels of TSHR mRNA than nondifferentiated OF cultures. Stimulation by rhTSH induced a marked cAMP response in 11 of 12 differentiated OF cultures, but no measurable HA response in all but one differentiated OF cultures. By contrast, stimulation by GD-IgG induced a moderate cAMP response in a number of differentiated OF cultures, but a marked HA response in the majority of differentiated OF cultures.
Conclusion: Stimulation of differentiated OF by GD-IgG, but not by rhTSH, induces HA synthesis in the majority of patients, suggesting that in most patients TSHR-mediated cAMP signaling does not play a pivotal role in GD-IgG-induced HA synthesis in differentiated OF cultures.
Similar articles
-
Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.Thyroid. 2010 May;20(5):535-44. doi: 10.1089/thy.2009.0447. Thyroid. 2010. PMID: 20384487
-
PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.J Clin Endocrinol Metab. 2012 Jun;97(6):E944-53. doi: 10.1210/jc.2012-1020. Epub 2012 Mar 21. J Clin Endocrinol Metab. 2012. PMID: 22438231
-
Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist.J Clin Endocrinol Metab. 2012 May;97(5):E781-5. doi: 10.1210/jc.2011-2931. Epub 2012 Mar 14. J Clin Endocrinol Metab. 2012. PMID: 22419705
-
Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.Exp Eye Res. 2016 Jan;142:83-91. doi: 10.1016/j.exer.2015.02.007. Exp Eye Res. 2016. PMID: 26675405 Review.
-
Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?J Clin Endocrinol Metab. 2011 Aug;96(8):2386-94. doi: 10.1210/jc.2011-0307. Epub 2011 Jun 15. J Clin Endocrinol Metab. 2011. PMID: 21677036 Review.
Cited by
-
Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.Thyroid. 2015 Oct;25(10):1145-50. doi: 10.1089/thy.2015.0254. Epub 2015 Aug 19. Thyroid. 2015. PMID: 26213859 Free PMC article.
-
Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy.Eye (Lond). 2019 Feb;33(2):191-199. doi: 10.1038/s41433-018-0315-9. Epub 2019 Jan 4. Eye (Lond). 2019. PMID: 30610229 Free PMC article.
-
Safety of total thyroid ablation in patients with Graves' orbitopathy.J Endocrinol Invest. 2016 Oct;39(10):1199-201. doi: 10.1007/s40618-016-0485-x. Epub 2016 May 20. J Endocrinol Invest. 2016. PMID: 27206633 No abstract available.
-
The role of cell mediated immunopathogenesis in thyroid-associated ophthalmopathy.Int J Ophthalmol. 2019 Jul 18;12(7):1209-1214. doi: 10.18240/ijo.2019.07.24. eCollection 2019. Int J Ophthalmol. 2019. PMID: 31341815 Free PMC article. Review.
-
Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatment.Eur Thyroid J. 2014 Dec;3(4):217-26. doi: 10.1159/000367968. Epub 2014 Dec 6. Eur Thyroid J. 2014. PMID: 25759797 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials